Following with our compromise of improving and expanding our branding and resources offered to the pharmaceutical industry during their process of “Drug Discovery”, Synthelia has made a new step further by setting up a strategical alliance with the Fundación Medina. Such association would cover both requirements; chemistry and biology needs for basic research.
Fundación Medina is non-profit research institution created in 2008 as a result of a public-private interface between the Regional Government of Andalusia, the pharmaceutical company Merck Sharp & Dohme Spain S.A. (MSD) and the University of Granada.
Their excellence arose from their expert team, the majority of the researches come from CIBE (Centro de Investigación Básica de MSD España), a platform well known for being very successful on time and quantity, over 50 years on the discovery and development of drugs from natural products.
More details about Fundación Medina: http://www.medinadiscovery.com/es/